Millie
your market intelligence analyst
Search Results
220 results
Your search is now limited to «Sanofi» expert search.
FiercePharmaManufacturing 08/22/2019 11:00
Philippines officials nix Sanofi's attempt to bring Dengvaxia back to market.
More from FiercePharmaManufacturing:
PharmiWeb.com 08/22/2019 01:50
Latest Research on “Global Insulin API Market 2019: Rising Industry Forecast Covering Growth Tendencies and Developments Until 2029.“Insulin API Market report delivers the clean elaborated structure of the market including each and every business-related important information of the market. The complete range of information is obtained through various sources and this obtained bulk of the information is arranged, processed, and represented by a group of specialists through the application of...
More from PharmiWeb.com:
GlobeNewswire 08/19/2019 11:36
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority)
More from GlobeNewswire:
Reuters.com 08/15/2019 16:28
A federal judge has rejected a bid by patients who allege Sanofi SA's cancer treatment Taxotere caused their permanent hair loss to prevent the drugmaker from presenting expert testimony based on an ex-employee's new analysis that showed minimal such side effects.
More from Reuters.com:
PR Newswire 08/13/2019 04:53
Data collected from 1,266 multiple sclerosis (MS) patients recently switched to a new DMT within the three months prior to fielding reveal Novartis' Gilenya, Sanofi's Aubagio, and Biogen's Tysabri and Tecfidera as the switch segment leaders in Europe.
More from PR Newswire:
Pharmafile 08/07/2019 07:22
Sanofi's Dupixent improves skin clearance in paediatric atopic dermatitis.
More from Pharmafile:
MedCity News 08/06/2019 14:14
The companies also reported a European dermatitis approval and successful topline results from a Phase III study of the drug, Dupixent.
More from MedCity News:
News-Medical.net 08/06/2019 09:47
Aug 6 2019 Exscientia, the world-leading Artificial Intelligence (AI)-driven drug discovery company, today announced that Sanofi has exercised its option to progress an innovative Bispecific Small molecule project it discovered as part of its new modality collaboration.
More from News-Medical.net:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications